Lataa...
Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases
Historically, metastatic melanoma was uniformly and rapidly lethal, and treatment options were limited. In recent years, however, checkpoint inhibitors have emerged as an accepted standard treatment for patients with advanced melanoma. In clinical trials, these agents have been largely well tolerate...
Tallennettuna:
| Julkaisussa: | J Investig Med High Impact Case Rep |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084516/ https://ncbi.nlm.nih.gov/pubmed/27826593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709616674316 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|